{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:16:27Z","timestamp":1768806987455,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"grant from the Science and Technology Commission of Changning District, Shanghai","award":["CNKW2022Y16"],"award-info":[{"award-number":["CNKW2022Y16"]}]},{"name":"grant from the Health Commission of Changning District\uff0cShanghai","award":["RCJD2021S01"],"award-info":[{"award-number":["RCJD2021S01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01580-4","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:42:48Z","timestamp":1738057368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sempervirine inhibits proliferation, invasion and metastasis of ovarian cancer cells and induces ultrastructural changes in vivo"],"prefix":"10.1186","volume":"18","author":[{"given":"Danni","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"4","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3322\/caac.21609","volume":"70","author":"Erratum","year":"2020","unstructured":"Erratum. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1580_CR2","first-page":"561","volume":"91","author":"SM Penny","year":"2020","unstructured":"Penny SM. Ovarian Cancer: an overview. Radiol Technol. 2020;91(6):561\u201375.","journal-title":"Radiol Technol"},{"issue":"2","key":"1580_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian Cancer: an Integrated Review. Semin Oncol Nurs. 2019;35(2):151\u20136.","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10(4):211\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"1580_CR5","doi-asserted-by":"crossref","unstructured":"Morand S, Devanaboyina M, Staats H, Stanbery L, Nemunaitis J. Ovarian Cancer Immunotherapy and Personalized Medicine. Int J Mol Sci 2021, 22 (12).","DOI":"10.3390\/ijms22126532"},{"issue":"10","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr., Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill F. R., Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"1580_CR7","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869\u201383.","journal-title":"Oncogene"},{"issue":"5","key":"1580_CR8","first-page":"2126","volume":"13","author":"L Han","year":"2023","unstructured":"Han L, Chen Y, Zheng A, Chen H. Incidence and risk factors for venous thromboembolism in patients with ovarian cancer during neoadjuvant chemotherapy: a meta-analysis. Am J Cancer Res. 2023;13(5):2126\u201334.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12094-007-0138-9","volume":"9","author":"M Gordaliza","year":"2007","unstructured":"Gordaliza M. Natural products as leads to anticancer drugs. Clin Transl Oncol. 2007;9(12):767\u201376.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of New drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod. 2020;83(3):770\u2013803.","journal-title":"J Nat Prod"},{"issue":"2","key":"1580_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.biotechadv.2018.02.002","volume":"36","author":"JF Buyel","year":"2018","unstructured":"Buyel JF. Plants as sources of natural and recombinant anti-cancer agents. Biotechnol Adv. 2018;36(2):506\u201320.","journal-title":"Biotechnol Adv"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"104845","DOI":"10.1016\/j.bioorg.2021.104845","volume":"112","author":"L Wang","year":"2021","unstructured":"Wang L, Jiang Y, Yaseen A, Li F, Chen B, Shen XF, Zheng C, Zhang GL, Wang MK. Steroidal alkaloids from the bulbs of Fritillaria Pallidiflora Schrenk and their anti-inflammatory activity. Bioorg Chem. 2021;112:104845.","journal-title":"Bioorg Chem"},{"issue":"1","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jep.2014.01.003","volume":"152","author":"GL Jin","year":"2014","unstructured":"Jin GL, Su YP, Liu M, Xu Y, Yang J, Liao KJ, Yu CX. Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)--a review of their phytochemistry, pharmacology, toxicology and traditional use. J Ethnopharmacol. 2014;152(1):33\u201352.","journal-title":"J Ethnopharmacol"},{"key":"1580_CR14","volume-title":"Zhong Hua Ben Cao","author":"EC Cao","year":"1999","unstructured":"Cao EC, o. ZHB. Zhong Hua Ben Cao. Shanghai: Shanghai Scientific and Technical Publishers China; 1999."},{"issue":"4160","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/164141a0","volume":"164","author":"R Bentley","year":"1949","unstructured":"Bentley R, Stevens TS. Structure of sempervirine. Nature. 1949;164(4160):141.","journal-title":"Nature"},{"issue":"5","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1021\/acs.joc.6b00022","volume":"81","author":"X Pan","year":"2016","unstructured":"Pan X, Yang C, Cleveland JL, Bannister TD. Synthesis and cytoxicity of Sempervirine and Analogues. J Org Chem. 2016;81(5):2194\u2013200.","journal-title":"J Org Chem"},{"issue":"21","key":"1580_CR17","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1021\/acs.joc.6b01092","volume":"81","author":"D Sucunza","year":"2016","unstructured":"Sucunza D, Cuadro AM, Alvarez-Builla J, Vaquero JJ. Recent advances in the synthesis of Azonia Aromatic Heterocycles. J Org Chem. 2016;81(21):10126\u201335.","journal-title":"J Org Chem"},{"issue":"27","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1021\/jacs.8b05095","volume":"140","author":"JK Kerkovius","year":"2018","unstructured":"Kerkovius JK, Kerr MA. Total synthesis of Isodihydrokoumine, (19 Z)-Taberpsychine, and (4 R)-Isodihydroukoumine N(4)-Oxide. J Am Chem Soc. 2018;140(27):8415\u20139.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000226363","volume":"43","author":"M Beljanski","year":"1986","unstructured":"Beljanski M, Beljanski MS. Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs. Oncology. 1986;43(3):198\u2013203.","journal-title":"Oncology"},{"issue":"1","key":"1580_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41420-020-00345-4","volume":"6","author":"C Caggiano","year":"2020","unstructured":"Caggiano C, Guida E, Todaro F, Bielli P, Mori M, Ghirga F, Quaglio D, Botta B, Moretti F, Grimaldi P, Rossi P, Jannini EA, Barchi M, Dolci S. Sempervirine inhibits RNA polymerase I transcription independently from p53 in tumor cells. Cell Death Discov. 2020;6(1):111.","journal-title":"Cell Death Discov"},{"issue":"10","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/sj.cdd.4400419","volume":"5","author":"S Fulda","year":"1998","unstructured":"Fulda S, Scaffidi C, Pietsch T, Krammer PH, Peter ME, Debatin KM. Activation of the CD95 (APO-1\/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Cell Death Differ. 1998;5(10):884\u201393.","journal-title":"Cell Death Differ"},{"key":"1580_CR22","doi-asserted-by":"crossref","unstructured":"Lin L, Hutzen B, Lee HF, Peng Z, Wang W, Zhao C, Lin HJ, Sun D, Li PK, Li C, Korkaya H, Wicha MS, Lin J. Evaluation of STAT3 signaling in ALDH\u2009+\u2009and ALDH+\/CD44+\/CD24- subpopulations of breast cancer cells. PLoS ONE 2013, 8 (12), e82821.","DOI":"10.1371\/journal.pone.0082821"},{"issue":"7","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1002\/ptr.7089","volume":"35","author":"B Deng","year":"2021","unstructured":"Deng B, Jiang XL, Tan ZB, Cai M, Deng SH, Ding WJ, Xu YC, Wu YT, Zhang SW, Chen RX, Kan J, Zhang EX, Liu B, Zhang JZ. Dauricine inhibits proliferation and promotes death of melanoma cells via inhibition of Src\/STAT3 signaling. Phytother Res. 2021;35(7):3836\u201347.","journal-title":"Phytother Res"},{"issue":"7","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.molonc.2016.04.003","volume":"10","author":"DB Avtanski","year":"2016","unstructured":"Avtanski DB, Nagalingam A, Tomaszewski JE, Risbood P, Difillippantonio MJ, Saxena NK, Malhotra SV, Sharma D. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis. Mol Oncol. 2016;10(7):1118\u201332.","journal-title":"Mol Oncol"},{"key":"1580_CR25","doi-asserted-by":"publisher","first-page":"806091","DOI":"10.3389\/fphar.2021.806091","volume":"12","author":"R Yue","year":"2021","unstructured":"Yue R, Liu H, Huang Y, Wang J, Shi D, Su Y, Luo Y, Cai P, Jin G, Yu C. Sempervirine inhibits proliferation and promotes apoptosis by regulating Wnt\/\u03b2-Catenin pathway in human hepatocellular carcinoma. Front Pharmacol. 2021;12:806091.","journal-title":"Front Pharmacol"},{"key":"1580_CR26","doi-asserted-by":"publisher","first-page":"770667","DOI":"10.3389\/fphar.2021.770667","volume":"12","author":"G Li","year":"2021","unstructured":"Li G, Zhong Y, Wang W, Jia X, Zhu H, Jiang W, Song Y, Xu W, Wu S. Sempervirine mediates autophagy and apoptosis via the Akt\/mTOR signaling pathways in Glioma cells. Front Pharmacol. 2021;12:770667.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86(3):353\u201364.","journal-title":"Cell"},{"issue":"5","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"3","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053\u201364.","journal-title":"Am J Pathol"},{"issue":"2","key":"1580_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275\u201392.","journal-title":"Cell"},{"issue":"34","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","volume":"23","author":"DA Altomare","year":"2004","unstructured":"Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004;23(34):5853\u20137.","journal-title":"Oncogene"},{"issue":"14","key":"1580_CR32","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","volume":"13","author":"S Mabuchi","year":"2007","unstructured":"Mabuchi S, Altomare DA, Cheung M, Zhang L, Poulikakos PI, Hensley HH, Schilder RJ, Ozols RF, Testa JR. RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res. 2007;13(14):4261\u201370.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1580_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.advms.2020.02.002","volume":"65","author":"J Masoumi","year":"2020","unstructured":"Masoumi J, Jafarzadeh A, Khorramdelazad H, Abbasloui M, Abdolalizadeh J, Jamali N. Role of Apelin\/APJ axis in cancer development and progression. Adv Med Sci. 2020;65(1):202\u201313.","journal-title":"Adv Med Sci"},{"issue":"1","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.17219\/acem\/64876","volume":"27","author":"KJ B\u0142ochowiak","year":"2018","unstructured":"B\u0142ochowiak KJ, Sokalski J, Bodnar MB, Trzybulska D, Marsza\u0142ek AK, Witmanowski H. Expression of VEGF\u2081\u2086\u2085b, VEGFR1, VEGFR2 and CD34 in benign and malignant tumors of parotid glands. Adv Clin Exp Med. 2018;27(1):83\u201390.","journal-title":"Adv Clin Exp Med"},{"issue":"55","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.1038\/sj.onc.1210573","volume":"26","author":"SC Sorli","year":"2007","unstructured":"Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene. 2007;26(55):7692\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","volume":"296","author":"CM Cox","year":"2006","unstructured":"Cox CM, D\u2019Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006;296(1):177\u201389.","journal-title":"Dev Biol"},{"issue":"6","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/stem.1661","volume":"32","author":"LE Sidney","year":"2014","unstructured":"Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32(6):1380\u20139.","journal-title":"Stem Cells"},{"issue":"23\u201324","key":"1580_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.drudis.2006.10.011","volume":"11","author":"SC Sorli","year":"2006","unstructured":"Sorli SC, van den Berghe L, Masri B, Knibiehler B, Audigier Y. Therapeutic potential of interfering with apelin signalling. Drug Discov Today. 2006;11(23\u201324):1100\u20136.","journal-title":"Drug Discov Today"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01580-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:42:58Z","timestamp":1738057378000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01580-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}